Adaptimmune Therapeutics - 53 Year Dividend History | ADAP

Historical dividend payout and yield for Adaptimmune Therapeutics (ADAP) since 1971. The current TTM dividend payout for Adaptimmune Therapeutics (ADAP) as of April 18, 2024 is $0.00. The current dividend yield for Adaptimmune Therapeutics as of April 18, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.893B $0.060B
Adaptimmune Therapeutics plc is a biopharmaceutical company. The Company is focused on cancer immunotherapy products based on T-cell receptor platform. Adaptimmune Therapeutics plc is based in Abingdon, United Kingdom.
Stock Name Country Market Cap PE Ratio